fluoromisonidazole has been researched along with Carcinoma, Anaplastic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, YM; Kuge, Y; Nishikawa, Y; Okamoto, S; Onimaru, R; Peng, H; Shiga, T; Shirato, H; Takeuchi, W; Tamaki, N; Tsuchiya, K; Watanabe, S; Yasuda, K | 1 |
| Fu, M; Lv, B; Qiu, J; Wang, X; Zheng, X; Zhuo, W | 1 |
| Baxi, S; Beattie, B; Boyle, J; Chan, S; Ganly, I; Humm, J; Katabi, N; Lanning, R; Lee, N; Li, D; McBride, S; Mitrani, L; Morris, LG; Pfister, DG; Riaz, N; Schoder, H; Sherman, E; Wong, R; Yarusi, B; Zhang, Z | 1 |
| Ametamey, S; Honer, M; Jochum, W; Oehler, C; Pruschy, M; Riesterer, O | 1 |
| Chang, CW; Chen, KY; Chou, KL; Liu, RS; Wu, LC; Yang, DJ; Yeh, SH; Yen, SH; Yu, TW | 1 |
| Chang, CP; Chang, CW; Chen, KY; Chou, KL; Chu, LS; Liu, RS; Lui, MT; Wu, LC; Yeh, SH; Yen, SH | 1 |
1 trial(s) available for fluoromisonidazole and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma.
Topics: Adult; Aged; Carcinoma; Chemoradiotherapy; Female; Humans; Male; Middle Aged; Misonidazole; Oropharyngeal Neoplasms; Oxygen; Positron-Emission Tomography; Radiation Protection; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Treatment Outcome; Tumor Hypoxia | 2016 |
5 other study(ies) available for fluoromisonidazole and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors.
Topics: Adult; Aged; Carcinoma; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Misonidazole; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated | 2017 |
Topics: Adult; Carcinoma; Feasibility Studies; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiation Tolerance; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Sampling Studies; Treatment Outcome; Tumor Burden | 2017 |
Ionizing radiation antagonizes tumor hypoxia induced by antiangiogenic treatment.
Topics: Animals; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Screening Assays, Antitumor; Glucose Transporter Type 1; Humans; Immunohistochemistry; Mammary Neoplasms, Animal; Mice; Misonidazole; Neoplasm Transplantation; Neovascularization, Pathologic; Phthalazines; Positron-Emission Tomography; Pyridines; Transplantation, Homologous | 2006 |
Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma.
Topics: Carcinoma; Case-Control Studies; Cell Hypoxia; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Misonidazole; Nasopharyngeal Neoplasms; Nasopharynx; Neck Muscles; Radiation-Sensitizing Agents; Tomography, Emission-Computed | 1996 |
Detection of anaerobic odontogenic infections by fluorine-18 fluoromisonidazole.
Topics: Bacteria, Anaerobic; Bacterial Infections; Carcinoma; Case-Control Studies; Cell Hypoxia; Dental Caries; Dental Pulp Diseases; Fluorine Radioisotopes; Humans; Misonidazole; Nasopharyngeal Neoplasms; Periodontal Diseases; Predictive Value of Tests; Radiation-Sensitizing Agents; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |